UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(a)
AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(a)
(Amendment No. 2)*
Agritope, Inc.
-----------------------------------------------------
(Name of issuer)
Common Stock, $.01 par value per share
-----------------------------------------------------
(Title of class of securities)
00855D107
-----------------------------------------------------
(CUSIP Number)
Pierre Lefebvre
Vilmorin Clause & Cie
B.P. 1
63720 Chappes, France
011-33-4-73-63-43-72
with a copy to:
Piper Marbury Rudnick & Wolfe LLP
1251 Avenue of the Americas
New York, New York 10020-1104
Attention: Garry P. McCormack, Esq.
212-835-6210
---------------------------------------------
(Name, address and telephone number of person authorized
to receive notices and communications)
September 6, 2000
-----------------------------------------------------
(Date of event which requires filing of this statement)
If the filing person has previously filed a statement on Schedule
13G to report the acquisition which is the subject of this Schedule
13D, and is filing this statement because of Rule 13d-1(e),
13d-1(f) or 13d-1(g), check the following box |_|.
Note: Schedules filed in paper format shall include a signed
original and five copies of the Schedule, including all exhibits.
See Rule 13d-7(b) for other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment
containing information which would alter disclosures provided in a
prior cover page.
The information required on the remainder of this cover page shall
not be deemed to be "filed" for the purpose of Section 18 of the
Securities Exchange Act of 1934 (the "Act") or otherwise subject to
the liabilities of that section of the Act but shall be subject to
all other provisions of the Act (however, see the Notes).
Page 1 of 11
<PAGE>
CUSIP No. 00855D107 13D Page 2 of 11 Pages
----------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
American Bio Corp. IRS ID. No. 36-3087046
----------------------------------------------------------------------------
----------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
----------------------------------------------------------------------------
----------------------------------------------------------------------------
3 SEC USE ONLY
----------------------------------------------------------------------------
----------------------------------------------------------------------------
4 SOURCE OF FUNDS*
AF
----------------------------------------------------------------------------
----------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e) |_|
----------------------------------------------------------------------------
----------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
----------------------------------------------------------------------------
--------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 651,785
--------------------------------------------------------------
--------------------------------------------------------------
SHARES 8 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 0
--------------------------------------------------------------
--------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 651,785
--------------------------------------------------------------
--------------------------------------------------------------
WITH 10 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------
----------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
651,785
----------------------------------------------------------------------------
----------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* |_|
----------------------------------------------------------------------------
----------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13.6%
----------------------------------------------------------------------------
----------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
HC, CO
----------------------------------------------------------------------------
SEE INSTRUCTIONS BEFORE FILLING OUT*
Page 2 of 11
<PAGE>
CUSIP No. 00855D107 13D Page 3 of 11 Pages
----------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Vilmorin Clause & Cie
----------------------------------------------------------------------------
----------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
----------------------------------------------------------------------------
----------------------------------------------------------------------------
3 SEC USE ONLY
----------------------------------------------------------------------------
----------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO
----------------------------------------------------------------------------
----------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e) |_|
----------------------------------------------------------------------------
----------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
France
----------------------------------------------------------------------------
--------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 651,785
--------------------------------------------------------------
--------------------------------------------------------------
SHARES 8 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 0
--------------------------------------------------------------
--------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 651,785
--------------------------------------------------------------
--------------------------------------------------------------
WITH 10 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------
----------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
651,785
----------------------------------------------------------------------------
----------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* |_|
----------------------------------------------------------------------------
----------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13.6%
----------------------------------------------------------------------------
----------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
HC, CO
----------------------------------------------------------------------------
SEE INSTRUCTIONS BEFORE FILLING OUT*
Page 3 of 11
<PAGE>
CUSIP No. 00855D107 13D Page 4 of 11 Pages
----------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Groupe Limagrain Holding S.A.
----------------------------------------------------------------------------
----------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
----------------------------------------------------------------------------
----------------------------------------------------------------------------
3 SEC USE ONLY
----------------------------------------------------------------------------
----------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO
----------------------------------------------------------------------------
----------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e) |_|
----------------------------------------------------------------------------
----------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
France
----------------------------------------------------------------------------
--------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 651,785
--------------------------------------------------------------
--------------------------------------------------------------
SHARES 8 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 0
--------------------------------------------------------------
--------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 651,785
--------------------------------------------------------------
--------------------------------------------------------------
WITH 10 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------
----------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
651,785
----------------------------------------------------------------------------
----------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* |_|
----------------------------------------------------------------------------
----------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13.6%
----------------------------------------------------------------------------
----------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
HC, CO
----------------------------------------------------------------------------
SEE INSTRUCTIONS BEFORE FILLING OUT*
Page 4 of 11
<PAGE>
CUSIP No. 00855D107 13D Page 5 of 11 Pages
----------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Societe Cooperative Agricole Limagrain
----------------------------------------------------------------------------
----------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
----------------------------------------------------------------------------
----------------------------------------------------------------------------
3 SEC USE ONLY
----------------------------------------------------------------------------
----------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO
----------------------------------------------------------------------------
----------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e) |_|
----------------------------------------------------------------------------
----------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
France
----------------------------------------------------------------------------
--------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 651,785
--------------------------------------------------------------
--------------------------------------------------------------
SHARES 8 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 0
--------------------------------------------------------------
--------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 651,785
--------------------------------------------------------------
--------------------------------------------------------------
WITH 10 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------
----------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
651,785
----------------------------------------------------------------------------
----------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* |_|
----------------------------------------------------------------------------
----------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13.6%
----------------------------------------------------------------------------
----------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
HC, OO
----------------------------------------------------------------------------
SEE INSTRUCTIONS BEFORE FILLING OUT*
Page 5 of 11
<PAGE>
This Amendment No. 2 amends and supplements the Statement on
Schedule 13D, dated September 28, 1999, as amended by Amendment No.
1 dated December 31, 1999 (as so amended, the "Schedule 13D"),
filed by Vilmorin Clause & Cie, a French societe anonyme
("Vilmorin"), Groupe Limagrain Holding S.A., a French societe
anonyme ("Groupe Limagrain"), and Societe Cooperative Agricole
Limagrain, a French agricultural cooperative (the "Cooperative"),
with respect to the Common Stock, $.01 par value per share (the
"Common Stock"), of Agritope, Inc., a Delaware corporation
("Agritope"). American Bio Corp., a Delaware corporation and a
direct, wholly-owned subsidiary of Vilmorin ("American Bio"), joins
in this filing. Capitalized terms used herein and not otherwise
defined herein have the meanings ascribed to them in the Schedule
13D.
Item 1. Security and Issuer
Item 1 of the Schedule 13D is hereby amended by deleting the
second paragraph thereof in its entirety and replacing it with
following paragraph:
None of the persons filing this Schedule 13D is a direct owner
of any shares of Common Stock. All shares of Common Stock that are
the subject of this Schedule 13D are indirectly beneficially owned
by virtue of American Bio Corp.'s record ownership of shares of
Agritope's Series A Convertible Preferred Stock (the "Series A
Preferred Stock") and warrants to purchase shares of Series A
Preferred Stock (the "Warrants"). Each share of Series A Preferred
Stock is convertible into one share of Common Stock, subject to
adjustment upon the occurrence of certain events, and is
convertible into Common Stock at any time at the election of the
holder. The Warrants may be exercised at any time prior to
September 28, 2004, at an exercise price of $7.00 per share of
Series A Preferred Stock, subject to adjustment upon the occurrence
of certain events.
Item 2. Identity and Background
Item 2 of the Schedule 13D is hereby amended and supplemented
by the addition of the following paragraphs:
(a), (b), (c), (f) This Schedule 13D is also filed by
American Bio Corp., a Delaware corporation and a direct,
wholly-owned subsidiary of Vilmorin ("American Bio"). American
Bio's principal business address is c/o Harris Moran Seed Company,
555 Codoni Avenue, Modesto, California 95352-4938. American Bio's
principal business is to hold shares of Vilmorin's U.S.
subsidiaries.
Set forth below are the name and present principal occupation
or employment of each executive officer and director of American
Bio. Each individual listed below is a citizen of France and has a
business address at B.P. 1, 63720 Chappes, France.
Page 6 of 11
<PAGE>
Name Present Principal Occupation or Employment
---- ------------------------------------------
Directors
---------
Gerard Renard Farmer
Jean-Denis Poulet Farmer
Francois Deloche Farmer
Raoul Faure Farmer
Francois Heyraud Farmer
Pierre Lefebvre Deputy CEO, Groupe Limagrain
Pascal Viguier Farmer
Executive Officers
Gerard Renard Farmer, Chairman of the Board, American Bio
Jean-Denis Poulet Farmer, Vice Chairman of the Board, American Bio
Francois Heyraud Farmer, Vice Chairman of the Board, American Bio
Pierre Lefebvre Vice President, American Bio; Deputy CEO,
Groupe Limagrain
Daniel Jacquemond Treasurer, American Bio
(d) During the last five years, neither American Bio nor, to
the best of its knowledge, any of its directors or executive
officers has been convicted in any criminal proceeding (excluding
traffic violations or similar misdemeanors).
(e) During the last five years, neither American Bio nor, to
the best of its knowledge, any of its directors or executive
officers was a party to a civil proceeding of a judicial or
administrative body of competent jurisdiction and as a result of
such proceeding was or is subject to a judgment, decree or final
order enjoining future violations of, or prohibiting or mandating
activities subject to, federal or state securities laws or finding
any violation with respect to such laws.
Item 3. Source and Amount of Funds or Other Consideration
Item 3 of the Schedule 13D is hereby amended and supplemented
by the addition of the following paragraph:
On September 6, 2000, Vilmorin contributed to the capital of
American Bio, its wholly-owned subsidiary, all of Vilmorin's
interest in Agritope, consisting of 564,285 shares of Series A
Preferred Stock and 87,500 Warrants. No consideration was paid by
American Bio for the securities.
Item 4. Purpose of Transaction
Item 4 of the Schedule 13D is hereby deleted in its entirety
and replaced with the following:
The responses to Items 3, 5 and 6 of this statement are
incorporated herein by reference.
Page 7 of 11
<PAGE>
Each of the persons filing this Schedule 13D currently holds
its direct or indirect interest in Agritope for investment
purposes. The persons filing this Schedule 13D intend to
continuously review their position in Agritope and, depending on
future evaluations of the business prospects of Agritope and on
other developments, including but not limited to general economic
and business conditions and stock market conditions, may retain or
from time to time increase their respective holdings or dispose of
all or a portion of their holdings in Agritope, subject to any
applicable legal and contractual restrictions on their ability to
do so.
Except as set forth in this Schedule 13D, none of the persons
filing this Schedule 13D has any present plans or proposals which
relate to or would result in: (a) any acquisition by any person of
additional securities of Agritope, or any disposition of securities
of Agritope, (b) any extraordinary corporate transaction, such as a
merger, reorganization or liquidation, involving Agritope or any of
its subsidiaries; (c) any sale or transfer of a material amount of
assets of Agritope or any of its subsidiaries; (d) any change in
the present board of directors or management of Agritope, including
any plans or proposals to change the number or term of directors or
to fill any existing vacancies on the board; (e)any material
change in the present capitalization or dividend policy of
Agritope; (f)any other material change in Agritope's business or
corporate structure; (g) any changes in Agritope's charter, by-laws
or corresponding instruments or other actions which may impede the
acquisition of control of Agritope by any person; (h) any delisting
from a national securities exchange or any loss of authorization
for quotation in an inter-dealer quotation system of a registered
national securities association of a class of securities of
Agritope; (i) any termination of registration pursuant to section
12(g)(4) of the Securities Exchange Act of 1934, as amended, of a
class of equity securities of Agritope; or (j) any action similar
to any of those enumerated above.
Item 5. Interest in Securities of the Issuer
Item 5 of the Schedule 13D is hereby deleted in its entirety
and replaced with the following:
The responses to Items 3, 4 and 6 of this statement are
incorporated herein by reference.
As of the date hereof, American Bio directly beneficially
owns, and each of Vilmorin, Groupe Limagrain and the Cooperative
indirectly beneficially owns, an aggregate of 651,785 shares of
Series A Preferred Stock, consisting of the following securities
that were transferred to American Bio by Vilmorin on September 6,
2000: (i) 214,285 shares of Series A Preferred Stock that Vilmorin
purchased in connection with a research and development
collaboration between Agritope and Vilmorin in December 1997; plus
(ii) 500,000 shares of Series A Preferred Stock that Vilmorin
purchased pursuant to the Unit Purchase Agreement; plus
(iii) Warrants to purchase an additional 125,000 shares of Series A
Preferred Stock that Vilmorin also purchased pursuant to the Unit
Purchase Agreement; less (iv) 150,000 shares of Series A Preferred
Stock and 37,500 Warrants that Vilmorin transferred to Hazera on
December 31, 1999, pursuant to the Letter Agreement.
The shares of Series A Preferred Stock are convertible into
shares of Common Stock pursuant to Section 6 of the Certificate of
Designation, Preferences and Rights of the Series A Preferred Stock
of Agritope, Inc. (the "Certificate of Designation"), which sets
forth a formula for determining the number of shares of Common
Stock issuable, as at any date, upon conversion of the Series A
Preferred Stock. Under the Certificate of Designation, each share
Page 8 of 11
<PAGE>
of Series A Preferred Stock is currently convertible at the option
of the holder into one share of Common Stock. Accordingly, the
shares of Series A Preferred Stock beneficially owned by the
persons filing this Schedule 13D, together with the shares of
Series A Preferred Stock issuable upon exercise of the Warrants,
are currently convertible into 651,785 shares of Common Stock.
Each of American Bio, directly, and Vilmorin, Groupe Limagrain and
the Cooperative, indirectly, has sole power to vote or direct the
vote and sole power to dispose or direct the disposition of the
651,785 shares of Common Stock issuable upon conversion of the
shares of Series A Preferred Stock beneficially owned by them.
These 651,785 shares of Common Stock represent approximately 13.6%
of the Common Stock outstanding, based on calculations made in
accordance with Rule 13d-3(d) of the Securities and Exchange Act of
1934, as amended, and based on there being 4,130,697 shares of
Common Stock outstanding as of June 30, 2000.
No other person is known to have the right to receive or the
power to direct the receipt of dividends from, or the proceeds of
the sale of, any securities of Agritope that are beneficially owned
by the persons filing this Schedule 13D.
Item 7. Material to be Filed as Exhibits
Item 7 of the Schedule 13D is hereby amended by deleting the
third paragraph thereof in its entirety and replacing it with
following paragraph:
Exhibit 99.3 Joint Filing Agreement among American Bio,
Vilmorin, Groupe Limagrain and the Cooperative pursuant to Rule
13d-1(k).
[REMAINDER OF PAGE INTENTIONALLY BLANK]
Page 9 of 11
<PAGE>
Signature
After reasonable inquiry and to the best of their knowledge
and belief, the undersigned certify that the information set forth
in this statement is true, complete and correct.
Dated: September 30, 2000
American Bio Corp
By: /s/ Pierre Lefebvre
Name: Pierre Lefebvre
Title: CEO
Vilmorin Clause & Cie
By: /s/ Pierre Lefebvre
Name: Pierre Lefebvre
Title: CEO
Groupe Limagrain Holding S.A.
By: /s/ Alain Catala
Name: Alain Catala
Title: CEO
Societe Cooperative Agricole
Limagrain
By: /s/ Alain Catala
Name: Alain Catala
Title: CEO
Page 10 of 11
<PAGE>
